# A Study to Evaluate CJC 1295 in HIV Patients With Visceral Obesity

> **NCT00267527** · PHASE2 · TERMINATED · sponsor: **ConjuChem** · enrollment: 120 (—)

## Conditions studied

- Obesity
- HIV Infections

## Interventions

- **DRUG:** CJC 1295

## Key facts

- **NCT ID:** NCT00267527
- **Lead sponsor:** ConjuChem
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2005-12
- **Primary completion:** —
- **Final completion:** 2006-09
- **Target enrollment:** 120 (—)
- **Last updated:** 2006-10-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00267527

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00267527, "A Study to Evaluate CJC 1295 in HIV Patients With Visceral Obesity". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00267527. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*